KRAS and neoplasm: Conversely, we demonstrate that overexpression of KHKC in KPC cells enhances KRAS downstream pathway, while KHKA overexpression acts as a tumor suppressor by blocking the phosphorylation of ERK1/2 and decreasing RPS6 activation.